<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Horner, Daniel</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Anticoagulation for Isolated Distal Deep Vein Thrombosis May Reduce Serious Complications</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">10-11</style></pages><abstract><style  face="normal" font="default" size="100%">A feasibility study has provided new insight on the value of therapeutic anticoagulation for isolated distal deep vein thrombosis (IDDVT). This pilot study reported a nonsignificant trend toward reduction of serious complications, including the absence of major bleeding, with anticoagulation. The Anticoagulation of Calf Thrombosis trial [ACT; ISRCTN75175695] aimed to compare therapeutic anticoagulation against conservative management for patients with acute symptomatic IDDVT.</style></abstract><number><style face="normal" font="default" size="100%">13</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>